Clinical-stage biotechnology company developing medicines to make the curative potential of stem cell transplantation available to more patients with blood cancers, genetic diseases, and autoimmune diseases
Clinical-stage biotechnology company developing medicines to make the curative potential of stem cell transplantation available to more patients with blood cancers, genetic diseases, and autoimmune diseases. Its work combines stem cell biology and biotherapeutics development with clinical and regulatory expertise, with a focus on immune reset.